Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

Analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report issued on Saturday. The brokerage set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Up 3.2 %

NASDAQ:RKDA opened at $3.32 on Friday. The stock’s 50 day moving average price is $4.59 and its two-hundred day moving average price is $4.09. The firm has a market capitalization of $4.54 million, a price-to-earnings ratio of -0.78 and a beta of 0.86. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $10.31.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences at the end of the most recent quarter. Institutional investors own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.